Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fulcrum Therapeutics Inc FULC

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX... see more

Recent & Breaking News (NDAQ:FULC)

Fulcrum Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FULC

ACCESS Newswire September 18, 2024

Fulcrum Therapeutics Inc Is Being Inquired Into For Securities Fraud And Affected Shareholders Should Contact The Schall Law Firm

ACCESS Newswire September 18, 2024

Fulcrum Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - FULC

ACCESS Newswire September 18, 2024

Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire September 18, 2024

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Fulcrum Therapeutics, Inc. (FULC)

ACCESS Newswire September 17, 2024

The Schall Law Firm Seeks Investor Contributions To An Investigation Into Fulcrum Therapeutics, Inc. For Possible Securities Related Infractions

ACCESS Newswire September 17, 2024

FULC STOCK ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of an Ongoing Investigation

ACCESS Newswire September 17, 2024

Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

ACCESS Newswire September 17, 2024

Fulcrum Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - FULC

ACCESS Newswire September 16, 2024

Fulcrum Therapeutics Inc May Have Defrauded Shareholders And Those With Losses Are Urged To Take Part In The Schall Law Firm's Inquiry

ACCESS Newswire September 16, 2024

FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!

Business Wire September 16, 2024

ATTENTION FULC SHAREHOLDERS: Investors who lost money on Fulcrum Therapeutics, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

ACCESS Newswire September 16, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fulcrum Therapeutics, Inc. (FULC) and Encourages Stockholders to Learn More About the Investigation

ACCESS Newswire September 16, 2024

The Schall Law Firm Is Looking Into Whether Fulcrum Therapeutics, Inc. Violated Securities Laws And Affected Investors Should Reach Out

ACCESS Newswire September 15, 2024

Fulcrum Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- FULC

ACCESS Newswire September 15, 2024

FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!

PR Newswire September 15, 2024

Fulcrum Therapeutics, Inc. Being Investigated on Behalf of Fulcrum Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details.

ACCESS Newswire September 15, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therapeutics, Inc. (FULC) Investors to Inquire about Securities Investigation

ACCESS Newswire September 15, 2024

Did Fulcrum Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- FULC

ACCESS Newswire September 14, 2024

Shareholders In Fulcrum Therapeutics Inc Are Invited To Join The Schall Law Firm's Investigation Into Possible Securities Fraud

ACCESS Newswire September 14, 2024